Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MCW | Common Stock | Options Exercise | $131K | +198K | +7.87% | $0.66* | 2.72M | Jun 12, 2023 | Direct | |
transaction | MCW | Common Stock | Sale | -$1.76M | -198K | -7.3% | $8.87 | 2.52M | Jun 12, 2023 | Direct | F1, F2 |
transaction | MCW | Common Stock | Options Exercise | $51.3K | +77.7K | +8.1% | $0.66* | 1.04M | Jun 12, 2023 | by The JLKL 2020 Irrevocable Family Trust | |
transaction | MCW | Common Stock | Sale | -$689K | -77.7K | -7.49% | $8.87 | 960K | Jun 12, 2023 | by The JLKL 2020 Irrevocable Family Trust | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MCW | Stock Option (Right to Buy) | Options Exercise | $0 | -198K | -13.32% | $0.00 | 1.29M | Jun 12, 2023 | Common Stock | 198K | $0.66 | Direct | F3, F4 |
transaction | MCW | Stock Option (Right to Buy) | Options Exercise | $0 | -77.7K | -3.33% | $0.00 | 2.25M | Jun 12, 2023 | Common Stock | 77.7K | $0.66 | by The JLKL 2020 Irrevocable Family Trust | F3 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.65 to $8.95. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F2 | This amount reflects: the deduction of 38 shares erroneously included in Table I, Column 5 of the Reporting Person's Form 5 filed on 2/11/2022; and the exclusion of 320,000 Restricted Stock Units previously reported in Table I, Column 5 in the Form 4 filed on 6/30/22. |
F3 | The option is fully vested and exercisable. |
F4 | The option balance reported here includes 38 options which were omitted from the Form 3 filed on 6/25/2021, and subsequent Forms 4 filed on 7/1/2021, and 8/26/2021 due to administrative error. |
All transactions reported in this Form 4 were executed pursuant to a 10b5-1 trading plan adopted on March 13, 2023.